192 related articles for article (PubMed ID: 18198377)
21. Defining limits of treatment with humanized neutralizing monoclonal antibody for West Nile virus neurological infection in a hamster model.
Morrey JD; Siddharthan V; Olsen AL; Wang H; Julander JG; Hall JO; Li H; Nordstrom JL; Koenig S; Johnson S; Diamond MS
Antimicrob Agents Chemother; 2007 Jul; 51(7):2396-402. PubMed ID: 17452485
[TBL] [Abstract][Full Text] [Related]
22. Dynamics of Tissue-Specific CD8
Aguilar-Valenzuela R; Netland J; Seo YJ; Bevan MJ; Grakoui A; Suthar MS
J Virol; 2018 May; 92(10):. PubMed ID: 29514902
[TBL] [Abstract][Full Text] [Related]
23. Antibody prophylaxis and therapy against West Nile virus infection in wild-type and immunodeficient mice.
Engle MJ; Diamond MS
J Virol; 2003 Dec; 77(24):12941-9. PubMed ID: 14645550
[TBL] [Abstract][Full Text] [Related]
24. A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice.
Liu WJ; Wang XJ; Clark DC; Lobigs M; Hall RA; Khromykh AA
J Virol; 2006 Mar; 80(5):2396-404. PubMed ID: 16474146
[TBL] [Abstract][Full Text] [Related]
25. Genetic diversity in the collaborative cross model recapitulates human West Nile virus disease outcomes.
Graham JB; Thomas S; Swarts J; McMillan AA; Ferris MT; Suthar MS; Treuting PM; Ireton R; Gale M; Lund JM
mBio; 2015 May; 6(3):e00493-15. PubMed ID: 25944860
[TBL] [Abstract][Full Text] [Related]
26. Noncoding Subgenomic Flavivirus RNA Is Processed by the Mosquito RNA Interference Machinery and Determines West Nile Virus Transmission by Culex pipiens Mosquitoes.
Göertz GP; Fros JJ; Miesen P; Vogels CBF; van der Bent ML; Geertsema C; Koenraadt CJM; van Rij RP; van Oers MM; Pijlman GP
J Virol; 2016 Nov; 90(22):10145-10159. PubMed ID: 27581979
[TBL] [Abstract][Full Text] [Related]
27. Effect of interferon-alpha and interferon-inducers on West Nile virus in mouse and hamster animal models.
Morrey JD; Day CW; Julander JG; Blatt LM; Smee DF; Sidwell RW
Antivir Chem Chemother; 2004 Mar; 15(2):101-9. PubMed ID: 15185728
[TBL] [Abstract][Full Text] [Related]
28. Comparative pathology of neurovirulent lineage 1 (NY99/385) and lineage 2 (SPU93/01) West Nile virus infections in BALBc mice.
Williams JH; Mentoor JD; Van Wilpe E; Venter M
Vet Pathol; 2015 Jan; 52(1):140-51. PubMed ID: 24513801
[TBL] [Abstract][Full Text] [Related]
29. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis.
Wang T; Town T; Alexopoulou L; Anderson JF; Fikrig E; Flavell RA
Nat Med; 2004 Dec; 10(12):1366-73. PubMed ID: 15558055
[TBL] [Abstract][Full Text] [Related]
30. MAVS Expressed by Hematopoietic Cells Is Critical for Control of West Nile Virus Infection and Pathogenesis.
Zhao J; Vijay R; Zhao J; Gale M; Diamond MS; Perlman S
J Virol; 2016 Aug; 90(16):7098-7108. PubMed ID: 27226371
[TBL] [Abstract][Full Text] [Related]
31. Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis.
Desprès P; Combredet C; Frenkiel MP; Lorin C; Brahic M; Tangy F
J Infect Dis; 2005 Jan; 191(2):207-14. PubMed ID: 15609230
[TBL] [Abstract][Full Text] [Related]
32. The E glycoprotein plays an essential role in the high pathogenicity of European-Mediterranean IS98 strain of West Nile virus.
Alsaleh K; Khou C; Frenkiel MP; Lecollinet S; Vàzquez A; de Arellano ER; Després P; Pardigon N
Virology; 2016 May; 492():53-65. PubMed ID: 26896935
[TBL] [Abstract][Full Text] [Related]
33. The Interferon-Stimulated Gene Ifi27l2a Restricts West Nile Virus Infection and Pathogenesis in a Cell-Type- and Region-Specific Manner.
Lucas TM; Richner JM; Diamond MS
J Virol; 2015 Dec; 90(5):2600-15. PubMed ID: 26699642
[TBL] [Abstract][Full Text] [Related]
34. Minocycline Has Anti-inflammatory Effects and Reduces Cytotoxicity in an
Quick ED; Seitz S; Clarke P; Tyler KL
J Virol; 2017 Nov; 91(22):. PubMed ID: 28878079
[TBL] [Abstract][Full Text] [Related]
35. Blood-brain barrier breakdown and increased intercellular adhesion molecule (ICAM-1/CD54) expression after Semliki Forest (A7) virus infection facilitates the development of experimental allergic encephalomyelitis.
Erälinna JP; Soilu-Hänninen M; Röyttä M; Hukkanen V; Salmi AA; Salonen R
J Neuroimmunol; 1996 May; 66(1-2):103-14. PubMed ID: 8964903
[TBL] [Abstract][Full Text] [Related]
36. Immunization of flavivirus West Nile recombinant envelope domain III protein induced specific immune response and protection against West Nile virus infection.
Chu JH; Chiang CC; Ng ML
J Immunol; 2007 Mar; 178(5):2699-705. PubMed ID: 17312111
[TBL] [Abstract][Full Text] [Related]
37. West Nile virus immunoglobulin A (WNV IgA) detection in cerebrospinal fluid in relation to WNV IgG and IgM reactivity.
Nixon ML; Prince HE
J Clin Virol; 2006 Nov; 37(3):174-8. PubMed ID: 16939715
[TBL] [Abstract][Full Text] [Related]
38. CD40-CD40 ligand interactions promote trafficking of CD8+ T cells into the brain and protection against West Nile virus encephalitis.
Sitati E; McCandless EE; Klein RS; Diamond MS
J Virol; 2007 Sep; 81(18):9801-11. PubMed ID: 17626103
[TBL] [Abstract][Full Text] [Related]
39. Virus entry and replication in the brain precedes blood-brain barrier disruption during intranasal alphavirus infection.
Cain MD; Salimi H; Gong Y; Yang L; Hamilton SL; Heffernan JR; Hou J; Miller MJ; Klein RS
J Neuroimmunol; 2017 Jul; 308():118-130. PubMed ID: 28501330
[TBL] [Abstract][Full Text] [Related]
40. Inactivated West Nile Virus (WNV) vaccine, Duvaxyn WNV, protects against a highly neuroinvasive lineage 2 WNV strain in mice.
Venter M; van Vuren PJ; Mentoor J; Paweska J; Williams J
Vaccine; 2013 Aug; 31(37):3856-62. PubMed ID: 23820079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
